Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

NCT06608472 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Arterial Hypertension

Interventions

DRUG: N0877
DRUG: Benicar HCT ® Tablets 40 mg/25 mg

Sponsor

Eurofarma Laboratorios S.A.